The Gap between Estimated Incidence of End-Stage Renal Disease and Use of Therapy

Open Access

Peer-reviewed

Research Article

Shuchi Anand,

Affiliation Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California, United States of America
⨯
Asaf Bitton,

Affiliation Division of General Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Thomas Gaziano

* E-mail: tgaziano@partners.org

Affiliation Cardiovascular Medicine, Brigham & Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯

Reader Comments

There is an error on the map in figure 1. The color for North Korea and Taiwan is not correct.

No competing interests declared.

Chronic kidney disease
Is the Subject Area "Chronic kidney disease" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Medical dialysis
Is the Subject Area "Medical dialysis" applicable to this article?

Thanks for your feedback.
Asia
Is the Subject Area "Asia" applicable to this article?

Thanks for your feedback.
Africa
Is the Subject Area "Africa" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.
Europe
Is the Subject Area "Europe" applicable to this article?

Thanks for your feedback.
Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.